Stockscreener 앱 받기
2.04
4.62%
0.09
시간 외 거래:
2.03
-0.01
-0.49%
전일 마감가:
$1.95
열려 있는:
$2.02
하루 거래량:
46,318
Relative Volume:
0.62
시가총액:
$1.84M
수익:
$8.97M
순이익/손실:
$-15.21M
주가수익비율:
-0.0175
EPS:
-116.51
순현금흐름:
$-10.84M
1주 성능:
+15.91%
1개월 성능:
-16.05%
6개월 성능:
+939.23%
1년 성능:
+77.39%
1일 변동 폭
$1.958
$2.0752
1주일 범위
$1.709
$2.0752
52주 변동 폭
$0.19
$25.95
Nuwellis Inc Stock (NUWE) Company Profile
명칭
Nuwellis Inc
전화
952-345-4200
주소
12988 VALLEY VIEW ROAD, EDEN PRAIRIE
NUWE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NUWE
Nuwellis Inc
|
2.04 | 1.76M | 8.97M | -15.21M | -10.84M | -116.51 |
|
ABT
Abbott Laboratories
|
127.78 | 219.88B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.79 | 141.54B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
366.39 | 133.39B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.31 | 124.82B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.85 | 48.84B | 5.88B | 1.34B | 799.60M | 2.3489 |
Nuwellis Inc Stock (NUWE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-29 | 개시 | ROTH MKM | Buy |
Nuwellis Inc 주식(NUWE)의 최신 뉴스
Nuwellis (NUWE) Secures Patent for Innovative Blood Filtration S - GuruFocus
Nuwellis receives patent for blood filtration safety mechanisms - Investing.com
Nuwellis Announces Issuance of New U.S. Patent Supporting Advanced Safety Design for Pediatric Extracorporeal Therapy - The Manila Times
Nuwellis, Inc. Receives New Patent for Safety Mechanisms in Pediatric Blood Filtration Systems - Quiver Quantitative
Insider Trends: Why Nuwellis Inc stock remains on buy listsJuly 2025 Technicals & Daily Profit Maximizing Trade Tips - moha.gov.vn
Stock Market Recap: Why analysts upgrade Nuwellis Inc stockTrade Exit Report & Verified Short-Term Plans - moha.gov.vn
Nuwellis says US children’s hospital initiates Aquadex ultrafiltration program - MSN
Nuwellis outlines Q3 recovery and strategic shift after resolving $400,000 back order - MSN
Nuwellis Shares Drop as Company Halts REVERSE-HF Clinical Trial - MSN
Nuwellis Q3 Earnings Preview - MSN
Critical Review: PROCEPT BioRobotics (NASDAQ:PRCT) vs. Nuwellis (NASDAQ:NUWE) - Defense World
Can Nuwellis Inc. stock rebound after recent weakness2025 EndofYear Setup & Short-Term Trading Alerts - Улправда
Nuwellis (NUWE) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Aug Retail: Why Nuwellis Inc stock remains on buy listsBond Market & Breakout Confirmation Alerts - moha.gov.vn
Is Nuwellis Inc. stock positioned well for digital economyShort Setup & High Accuracy Trade Alerts - Улправда
Will Nuwellis Inc. stock split again soonPortfolio Growth Summary & Smart Swing Trading Alerts - Улправда
Why Nuwellis Inc. stock remains on buy listsJuly 2025 Recap & Weekly Momentum Picks - DonanımHaber
Will Nuwellis Inc. stock sustain high P E ratiosMarket Performance Recap & Technical Pattern Alert System - Bölüm Sonu Canavarı
Earnings Update: Will Nuwellis Inc. stock sustain high P E ratios2025 Support & Resistance & Real-Time Chart Breakout Alerts - DonanımHaber
Market Pulse: Why retail investors pile into Nuwellis Inc. stockJuly 2025 Macro Moves & Consistent Return Investment Signals - Улправда
Why retail investors pile into Nuwellis Inc. stock2025 Price Targets & Long-Term Growth Portfolio Plans - Улправда
Chart Watch: Will Nuwellis Inc. stock attract ESG investors2025 Volume Leaders & Weekly High Return Stock Forecasts - Улправда
ETF Watch: Is Nuwellis Inc stock ready for breakout2025 Technical Patterns & Free Weekly Chart Analysis and Trade Guides - moha.gov.vn
Head to Head Analysis: Autonomix Medical (NASDAQ:AMIX) & Nuwellis (NASDAQ:NUWE) - Defense World
Nuwellis Earnings Notes - Trefis
Surprises Report: Why Nuwellis Inc stock is a must watch in 2025Portfolio Return Summary & Reliable Price Breakout Signals - moha.gov.vn
Nuwellis announces presentation of data on broad utility of Aquadex - MSN
Nuwellis, Inc. Announces the Presentation of New Real-World Data from New York City's Lenox Hill Hospital at the 2025 American Society of Nephrology Kidney Week - marketscreener.com
Nuwellis Stock Jump Looks Great, But How Secure Is That Gain? - Trefis
Nuwellis (NUWE) Reveals Promising Data on Aquadex Therapy at ASN Kidney Week 2025 - GuruFocus
Lenox Hill Hospital Study Highlights the Broad Utility of Aquadex in Managing Fluid Overload Across Critical Care Settings - The Manila Times
Nuwellis, Inc. Showcases Real-World Data on Aquadex® Therapy for Acute Kidney Injury at ASN Kidney Week 2025 - Quiver Quantitative
Would You Still Hold Nuwellis Stock If It Fell Another 30%? - Trefis
With Nuwellis Stock Sliding, Have You Assessed The Risk? - Trefis
Nuwellis Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis
How Nuwellis Inc. stock compares to market leadersWeekly Profit Analysis & Free Daily Entry Point Trade Alerts - Newser
Nuwellis expands pediatric presence with new children’s hospital adoption By Investing.com - Investing.com Nigeria
Nuwellis (NUWE) Expands with New Aquadex Program in Northeastern Children's Hospital - GuruFocus
Nuwellis expands pediatric presence with new children’s hospital adoption - Investing.com
Nuwellis Continues Clinician-Driven Growth in Pediatric Care with a Leading Hospital in the Northeast U.S. - The Manila Times
Nuwellis (Nasdaq: NUWE) grows clinician-led Aquadex adoption in U.S. pediatric hospitals - Stock Titan
Is Nuwellis Stock Built to Withstand More Downside? - Trefis
Nuwellis Appoints John L. Erb as Interim CFO - MSN
How does Nuwellis Inc (NUWE) change from a tortoise to a hare? - Setenews
Nuwellis (NUWE) Gets a Hold from Maxim Group - The Globe and Mail
Is Nuwellis Inc. stock a buy on dips2025 Investor Takeaways & Expert Verified Movement Alerts - newser.com
Maxim Group Maintains Nuwellis(NUWE.US) With Hold Rating, Announces Target Price $3.9 - 富途牛牛
Will Nuwellis Inc. stock benefit from commodity pricesRate Hike & Low Risk Investment Opportunities - newser.com
Will Nuwellis Inc. stock benefit from green energy trendsTrade Exit Report & Verified Short-Term Trading Plans - newser.com
Nuwellis Inc (NUWE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.82%
자본화:
|
볼륨(24시간):